An enzyme-linked immunosorbent assay (ELISA) was developed and compared with 2 reference diagnostic tests (indirect immunofluorescence [IF] and complement fixation) to detect myxoma virus-specific antibodies in sera from 50 rabbits experimentally vaccinated with an attenuated strain of myxoma virus or with a Shope fibroma virus. The ELISA was highly specific (100% specificity) and sensitive (100%, 21 days after homologous vaccination). In a comparison of the ELISA with the IF test in 128 wild rabbits from France, discrepant results were obtained in only 11 (8.6%) animals, which were positive with the ELISA and negative with the IF test. The higher sensitivity and the good specificity of the ELISA was confirmed in a serologic survey of 118 rabbits from 2 Kerguelen (Indian Ocean) islands, where the prevalence of myxomatosis varied considerably. The ELISA is an alternative serologic test for diagnosis, vaccine evaluation, and seroepidemiologic surveys of myxomatosis.
Myxomatosis is a specific viral disease of the European rabbit (Oryctolagus cuniculus), causing severe or attenuated clinical manifestations in domestic and wild rabbit populations. 4, 6, 7, 13 The etiologic agent of myxomatosis is a large double-stranded DNA virus in the Leporipoxvirus genus of the Poxviridae family. It was released in Australia and Europe in 1950 and 1952, respectively, as a biological control for wild rabbits. Myxomatosis is now endemic in European and Australian rabbit populations. Diagnosis is generally based on clinical signs alone, but the occurrence of atypical cases 11 with an absence of myxoma lesions has revealed the need for specific and sensitive diagnostic tests.
The immune response in infected rabbits is characterized by the early appearance and persistence for several months of specific antibodies that may be detected by complement fixation (CF) 2,5,7 virus neutralization, 5 immunodiffusion, 17, 18 or immunofluorescence 3, 10 tests. These tests are adequate for most purposes but are time consuming and not really suitable for the estimation of disease prevalence in wild animals. Furthermore, they do not allow precise quantification of the antibody levels in animal serum. Previously, an enzyme-linked immunosorbent assay (ELISA) was developed using virus extracted from the skin tissue of infected rabbits as antigen. 20 The inter-assay reproducibility of the test was unsatisfactory, probably because of the poor quality of the antigen. 20 The ELISA described here was based on purified myxoma virus antigen and is compared with other serologic methods. It proved to be sensitive and specific for the detection of myxoma antibodies both in fresh serum and in dried blood on a blotter. The method was evaluated for diagnosis with sera from vaccinated and wild rabbit.
Material and methods
Blood specimens. Fifty domestic New Zealand White rabbits a were vaccinated intradermally with 5.10 3 plaque-forming units (PFU) of the SG33 French attenuated strain 15 of myxoma virus at the age of 10 wk. This viral strain was grown on primary chicken embryo fibroblasts. Samples were taken at different times after vaccination. Twelve of these 50 rabbits were challenged with the virulent T1 French reference strain of myxoma virus on day 45 after vaccination (day 0). Samples were taken 75, 105, and 135 days after challenge.
Thirty rabbits were vaccinated with heterologous Shope fibroma virus, b and samples were collected before (day 0) and 21 days after vaccination.
One hundred twenty-eight specimens were collected at random from wild rabbits in the French Arboretum de Chevreloup over a period of several years. Samples were dried on small sheets of blotter and stored at Ϫ20 C until use. Two discs of punched blotter (6 mm diameter) were rehydrated in 100 l of phosphate-buffered saline (PBS) in a 96-well microplate and stored at 4 C overnight. The eluate was then used directly in serologic tests as equivalent to a 1/20 dilution of fresh serum. 10 One hundred eighteen specimens were collected from wild . Viral antigens. Monolayers of rabbit kidney cells (RK13 c ) were infected with the French wild strain of myxoma virus T1 at a multiplicity of infection of 1 in medium d supplemented with 2% fetal calf serum. When the cytopathic effect had attained 75-100%, the cells were scraped off with a rubber policeman, pelleted by low-speed centrifugation, and washed once in TL20 buffer (150 mM NaCl, 1 mM ethylenediaminetetraacetic acid, 20 mM Tris-HCl, pH 8.6). The pelleted cells were then suspended in TL20 buffer and put on ice for 90 min (or overnight), after which the cell suspension was homogenized in a Dounce homogenizer and centrifuged at 1,200 ϫ g (2,500 rpm) in a low-speed centrifuge e for 10 min.
The supernatant was collected and layered on a 36% sucrose cushion (in TL20 buffer) and then ultracentrifuged at 200,000 ϫ g (30,000 rpm, SW 41.14 rotor f ) for 2 hr. The resulting pellet was resuspended in TL20 buffer. Protein concentrations were determined by the Bradford method. 1 Usually, 1 ml of the suspension contained 5-40 mg of total protein, and the estimated concentration of viral proteins was 60%.
Indirect immunofluorescence test. The indirect immunofluorescence test (IFT) was derived from that previously described. 10 The antigen consisted of monolayers of T1-infected RK13 cells in flat-bottom microplates. Twenty-four hours after infection, the cells were washed twice in PBS and fixed with 80% acetone in distilled water at Ϫ20 C for 30 min. Serial dilutions of serum samples were incubated for 2 hr with cells and the fixation of specific antibodies was revealed with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (1:200 in PBS). Fluorescence intensity was assessed by comparison with a standard intensity scale (1ϩ to 4ϩ). The serum sample titer was expressed as the inverse of the highest dilution for which the fluorescence intensity was at least 2ϩ. Titers below 20 were not considered positive.
CF test. The previously described CF test was used. 2 Antigen was prepared from cutaneous myxoma lesions developed in a rabbit inoculated with the virulent T1 French reference strain by intradermal route. The serum titer was determined as the highest dilution for which 50% inhibition of hemolysis was obtained. Titers below 4 were not considered positive.
ELISA. Assay microplates g were coated overnight at 37 C with viral proteins (800 ng to 1 g per well) diluted in PBS (pH 7.6) or with PBS only for one column as a blank. The wells were washed 3 times in PBS, and free binding sites were blocked by incubation in 15 mg/ml gelatin in PBS for 1 hr at 37 C. The plates were then washed 3 times in PBS-0.1% Tween 20, and serial 2-fold dilutions of serum samples in PBS-Tween were added. Positive and negative serum standards were included on each plate. After 60 min incubation at 37 C, the plates were washed 3 times in PBS-Tween, and a 1:3,000 dilution of goat anti-rabbit IgG serum conjugated to alkaline phosphatase h in PBS-Tween was added for 1 hr at 37 C. Finally after 4 washes in PBS-Tween, disodium p-nitrophenyl phosphate h at a concentration of 1 mg/ml in 10% diethanolamine was used as substrate. After 12 min at room temperature in the dark, the enzymatic reaction was stopped by the addition of 2 N NaOH, and absorbance was read in a spectrophotometer i at a wavelength of 405 nm. Each individual serum sample from 50 rabbits maintained free of myxoma virus a was tested both with ELISA and IFT. The sera were examined in duplicate at 1: 50 dilution to determine cutoff values for the positive results.
The absorbance values were equivalent to the absorbances obtained for wells containing antigen alone plus substrate. The absorbances for all negative sera were less than 2 times the mean of negative sera absorbance. The 50 sera were pooled and aliquoted to provide a standard negative serum control, which was included in each plate. To avoid falsepositive results, the serum sample titer was expressed as the inverse of the highest dilution for which the absorbance was greater than 3 times the absorbance of the negative serum standard. Titers below 100 were not considered positive.
Statistical analysis. Correlation coefficients were calculated using a commercial computer program. j The agreement between IFT and ELISA was measured as a kappa value. 19 
Results
Comparison of the IFT, CF, and ELISA in experimental infections. To evaluate the specificity and sensitivity of this ELISA, sera from 50 animals vaccinated on day 0 with the SG33 strain of myxoma virus were used for the detection of specific antibodies using 2 reference methods (IFT and CF) and the ELISA method under test.
All preimmune sera were negative with all 3 techniques (Table 1) . Myxoma virus-specific antibodies were first detected on day 10 in 72%, 86%, and 98% of the tests with IFT, CF, and ELISA, respectively. All animals were detected positive on days 21 and 30 with IFT and ELISA, whereas only 78% were positive in the CF test. Forty-five days after inoculation, only 35% of the animals were detected as positive in the CF test compared with 98% in the IFT and 100% with ELISA ( Table 1 ). The mean of antibody titers obtained in the different tests are summarized in Fig. 1 . Maximum titers were obtained with the ELISA, suggesting that this technique is more sensitive. These results suggest that all 3 methods exhibit similar high specificity and that IFT and especially ELISA are more sensitive than CF. Twelve of the 50 animals were challenged with a virulent strain of myxoma virus on day 45 after vaccination, and the means of the kinetics of specific antibody production are given in Fig. 2 . This challenge induced a boost effect on the level of antibodies detected by all 3 tests, and the persistence of high titers of antibodies (i.e., above 80,000 by ELISA) could be observed 3 months after the challenge.
These results suggest that ELISA is valid for the detection of low titers of myxoma virus after vaccination and for the monitoring of antibody kinetics after experimental infection.
The same 3 techniques were also used to detect antibodies in Shope fibroma virus-vaccinated rabbits. Shope fibroma virus is a leporipoxvirus that shares antigenic characteristics with myxoma virus and has been used for heterologous safe vaccination of rabbits against myxomatosis. 8, 16, 21 Thirty rabbits vaccinated with a commercial preparation b were tested for leporipoxvirus antibodies. None of the rabbits had antibodies before vaccination (Table 2) , only 1 rabbit was positive in the CF test, and 2 were positive in the IFT 21 days later, whereas 100% were shown to be positive by ELISA. These results suggest that the difference among the 3 techniques was not due to higher specificity of CF or IFT (100% of preimmune sera were negative with all 3 tests) but rather to the low sensitivity of both techniques compared with the ELISA.
Natural infection in wild rabbits. Serum samples from 128 wild French rabbits of unknown myxomatosis infection status were then tested to evaluate the ELISA in wild rabbit populations. Blood samples were collected on a blotter and then eluted in PBS. The eluate was considered as a 1/20 dilution of the fresh serum. Serologic results determined by IFT (the reference for epidemiologic studies 3 ) were compared with the ELISA results. One hundred nineteen animals were positive with ELISA, and 108 were positive with IFT ( Table 3 ). Only 11 samples were positive with ELISA and negative with IFT. Figure 3 shows the means of the ELISA titer results in relation to the IFT titers obtained for the 128 samples. A close correlation was apparent with a correlation coefficient of 0.829 between the 2 methods.
To confirm these results, a population of 118 rabbits was also tested from the subantarctic Kerguelen Is- lands, where myxoma virus was introduced in 1956 in an attempt to control the rabbit populations. Spread of the virus in the absence of arthropod vectors probably occurred by direct contact between animals. 4 The prevalence of myxomatosis as determined by the IFT greatly depended on the island and the region under consideration (0-70%). 4 Sera from 68 rabbits from the island of Cimetiere, where Ͼ50% of the rabbits were seropositive for myxoma virus antibodies, 4 were tested by IFT and ELISA. Of these rabbits, 63% were positive with IFT, and 72% were positive with ELISA. Only 6 ELISA-positive sera were negative by IFT.
Fifty rabbits were also tested from the Molloy region of Grande Terre Island, where the prevalence of myxomatosis infection is very low (4%). 4 None of these rabbits were positive with IFT or ELISA.
The results obtained from the 246 wild rabbits (128 from France and 118 from the Kerguelen Islands) are summarized in Table 4 . The close agreement of the results is indicated by the Kappa value of 0.866; there were only 17 discrepant results between the ELISA and the IFT.
The 17 ELISA-positive, IFT-negative sera were tested at several dilutions in a semiquantitative ELISA. The highest dilutions for which sera were positive ranged from 1:100 to 1:800, thus suggesting that the ELISA detected lower antibody levels than did the IFT. Therefore, the increased number of positive sera detected by ELISA in the first comparative study probably was not due to false-positive reactions.
Discussion
In this study, a new ELISA was developed and evaluated to detect myxoma virus-specific antibodies in infected rabbits. As early as 10 days after inoculation with the myxoma virus, 98% of the experimentally vaccinated rabbits were positive by ELISA, and 100% were positive 11 days later. These results were more reliable than those obtained with the 2 other techniques. CF and IFT failed to detect any specific antibody in the Shope fibroma virus infection assays, although all rabbits survived after a challenge with myxoma virus (data not shown). Only the ELISA was suitable for the testing of vaccination efficiency with Shope fibroma virus, presumably because of the low level of specific antibodies that could not be detected with the 2 other methods ( Table 2 ). The higher sensitivity of ELISA and the feasibility of precise quantification of the antibodies (based on absorbance values) suggest that the ELISA may become extremely useful for kinetic studies of the immune response after vaccination with either a homologous vaccine or with Shope fibroma virus.
The sensitivity of the CF test in these experiments was low, with a high rate of false-negative results (26-65% depending on the delay between vaccination and sampling), as compared with that of the ELISA. The CF test was not therefore suitable for detecting low levels of antibodies. The sensitivity of the IFT was intermediate. This apparent lower sensitivity of IFT as compared with ELISA could be due to the difficulty of and subjectivity involved in interpreting fluorescence data.
In epidemiologic studies of wild animals, it is important to have a rapid and sensitive diagnostic test because of the large number of analyses needed and the unknown infection status of the animals. The se-roprevalence (i.e., apparent prevalence) of the disease is the number of positive animals divided by the number of animals tested. Estimation of the true prevalence is affected by the sensitivity and specificity of the test. 11, 12, 14 One reason for testing is to determine whether a population has been exposed to a particular pathogenic agent and to accurately determine its infection status. The results will depend on the properties of the test, the number of animals tested, the prevalence of infection, and the number of positive animals used to classify the population as positive. 9, 12 The IFT is currently being used to screen wild rabbit populations for myxoma virus-specific antibodies. 3, 10 The major drawback of this method is that it is not really convenient for the analysis of large numbers of samples because of the time required for interpretation of the results. Therefore, the ELISA was used in wild populations, and the results were compared with those obtained by IFT.
The prevalence of disease in the French rabbit population tested was very high, and discordance between ELISA and IFT was found in only 8.6% of the animals, presumably because of the lower sensitivity of IFT and not because of false-positive results.
However, to evaluate this false-positive possibility, wild rabbit populations from 2 regions of the Kerguelen Islands with high or low prevalence of myxoma virus infection were also tested. None of the 50 rabbits in the region where a very low prevalence of infection was demonstrated (i.e., Molloy region of Grande Terre Island) tested positive with ELISA. These results and the fact that the titers of discordant sera (negative by IFT and positive by ELISA) were below 1:800 strongly suggest that the increased number of positive samples detected with ELISA can be attributed to the higher sensitivity of the test.
The possibility of cross-reaction with other poxviruses can be excluded. No other member of the poxvirus family has been described in wild rabbit (O. cuniculus) populations; the host range of Shope fibroma virus in the wild is limited to the cottontail rabbit (Sylvilagus floridanus). Rabbitpoxvirus is the only member of the orthopoxvirus group that causes a disease of veterinary significance in O. cuniculus, but rabbitpoxvirus infections have only been described in rabbit colonies and never observed in the wild. 13 Rabbitpoxvirus is closely related to vaccinia virus (the prototype member of the genus Orthopoxvirus of the poxvirus family), and no cross-reaction between vaccinia virus and myxoma virus has been observed with the ELISA presented here (data not shown).
This ELISA detected seroconversion for myxoma virus in experimental infections earlier and at higher frequency than did other serologic methods and was highly specific. This test could be used with samples collected from wild rabbits onto a blotter and was easy to perform and suitable for handling large numbers of samples. More than 3,000 serum samples from wild rabbits have been screened by this technique since the beginning of this work.
The results presented in this study suggest that this ELISA could be used to circumvent certain limitations of the methods currently employed for the detection of myxoma virus antibodies and is likely to become a useful technique for the serodiagnosis of myxomatosis and for measurement of the response to vaccination.
